Los Angeles, CA -- (SBWire) -- 03/15/2019 --Anticancer Drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.
Anticancer drugs are agents that demonstrate activity against malignant disease. They include alkylating agents, antimetabolites, natural products, and hormones, as well as a variety of other chemicals that do not fall within these discrete classes but are capable of preventing the replication of cancer cells and thus are used in the treatment of cancer.
The global Anticancer Drug market is valued at 98300 million US$ in 2018 is expected to reach 165100 million US$ by the end of 2025, growing at a CAGR of 6.7% during 2019-2025.
This report focuses on Anticancer Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anticancer Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/986878/global-anticancer-drug-market
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Roche
Celgene
Pfizer
Bristol-Myers Squibb
Novartis
AstraZeneca
Teva Pharmaceuticals
Bayer
GlaxoSmithKline
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Targeted Drugs
Cytotoxic Drugs
Hormonal Drugs
Segment by Application
Immunotherapy
Targeted Therapy
Chemotherapy
Hormonal Therapy
Others
Get Complete Report in your Inbox within 24 hours: https://www.qyresearch.com/customize-request/form/986878/global-anticancer-drug-market
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.
Anticancer Drug Market Will Surge at 6.7% CAGR to Hit 165100 Million US$ by 2025: QY Research, Inc.